The EISAI GLOBAL CLINICAL DEVELOPMENT brand, founded in 2005 (Japan), from 125 sister brands and 4959 competing brands. The EISAI GLOBAL CLINICAL DEVELOPMENT brand is owned by Eisai, a company listed in Francfort. Its International Securities Identification Number (ISIN) is JP3160400002. EISAI GLOBAL CLINICAL DEVELOPMENT belongs to the Drug Manufacturers business sector.